HC
Haemonetics Corporation
🇺🇸XNYS.HAEUnited StatesHealthcare
$106.24USDup +1.01 (+0.96%)ClosedEnd of day6:49 AM
Price$106.24+1.01 (+0.96%)
Profile
- Healthcare
- Medical Devices
- United States
Identity
- Exchange
- New York Stock Exchange . XNYS
- Type
- Stock
- ISIN
- US4050241003
- CUSIP
- 405024100
Company
- Employees
- 3,009
- Headquarters
- Boston, United States
- Website
- https://www.haemonetics.com
- CEO
- Mr. Christopher A. Simon
Market
- Shares outstanding
- 45.5M
- Market cap
- $4.83B
Key dates
- Next earnings
- Nov 5, 2026
Highlights
- Market cap
- $4.83B
- EPS LTM
- $2.11
- P/E LTM
- 35.60
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $1.35B+0.44%up year on year
- Net income
- $96.29M-41.05%down year on year
- Gross margin
- 57.38%+0.98%up year on year
- Free cash flow
- $291.22M+53.95%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.